Histopathological Grade Versus Estrogen and Progestron Receptor Status in Carcinoma Breast- A Single Center Study

Journal of Medical Science And clinical Research
doi 10.18535/jmscr/v5i6.03
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Valley International

Related search

Histopathological Grade Versus Estrogen and Progestron Receptor Status in Carcinoma Breast- A Single Center Study

Open Access Journal of Surgery
2017English

Histopathological Grade Versus Hormone Receptor Status in Breast Carcinoma- Treasure the Past

International Journal of Biomedical Research
2015English

Expression of Estrogen and Progesterone Receptor Status in Breast Carcinoma Using Quick Score

Annals of Pathology and Laboratory Medicine
2018English

Study on Histopathological Correlation With ER, PR, and HER 2 Neu Receptor Status in Breast Carcinoma and Its Prognostic Importance

SSR Institute of International Journal of Life Sciences
2019English

Transcriptome‐wide Association Study of Breast Cancer Risk by Estrogen‐receptor Status

Genetic Epidemiology
EpidemiologyGenetics
2020English

Breast Cancer Incidence in Young Women by Estrogen Receptor Status and Race.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1989English

Estrogen and Progesterone Receptor Status in Breast Cancer: A Cross-Sectional Study of 450 Women in Kerala, South India

World Journal of Surgical Oncology
SurgeryOncology
2014English

Cigarette Smoking and Breast Cancer Risk in Relation to Joint Estrogen and Progesterone Receptor Status: A Case-Control Study in Japan

SpringerPlus
Multidisciplinary
2014English

Folate Intake and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy